©The Author(s) 2026.
World J Immunol. Jan 8, 2026; 16(1): 111511
Published online Jan 8, 2026. doi: 10.5411/wji.v16.i1.111511
Published online Jan 8, 2026. doi: 10.5411/wji.v16.i1.111511
Figure 11 Diagrammatic representation of the protective role of zingerone in diabetes and isoproterenol induced cardiac dysfunctions.
PKC: Protein kinase C; cAMP: Cyclic adenosine monophosphate; AGE: Advanced glycation end product; β1AR: Beta-1 adrenergic receptor.
- Citation: Singh B, Singh H, Kaur S, Singh B. Preclinical pharmacology studies of zingerone with special reference to potential therapeutic applications. World J Immunol 2026; 16(1): 111511
- URL: https://www.wjgnet.com/2219-2824/full/v16/i1/111511.htm
- DOI: https://dx.doi.org/10.5411/wji.v16.i1.111511